{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:21:42Z","timestamp":1790788902483,"version":"4.1.0"},"reference-count":283,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Health and Medical Research Council of Australia Practitioner Fellowship"},{"name":"Practitioner Fellowship from National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Asymptomatic arrhythmias are frequently encountered in clinical practice. Although studies specifically dedicated to these asymptomatic arrhythmias are lacking, many arrhythmias still require proper diagnostic and prognostic evaluation and treatment to avoid severe consequences, such as stroke or systemic emboli, heart failure, or sudden cardiac death. The present document reviews the evidence, where available, and attempts to reach a consensus, where evidence is insufficient or conflicting.<\/jats:p>","DOI":"10.1093\/europace\/euz046","type":"journal-article","created":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T15:06:56Z","timestamp":1551020816000},"page":"844-845","source":"Crossref","is-referenced-by-count":79,"title":["Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)"],"prefix":"10.1093","volume":"21","author":[{"given":"David O","family":"Arnar","sequence":"first","affiliation":[{"name":"Department of Medicine, Landspitali - The National University Hospital of Iceland and University of Iceland , Reykjavik,","place":["Iceland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges H","family":"Mairesse","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cliniques du Sud-Luxembourg , Arlon,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia , Policlinico di Modena, Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[{"name":"Department of Arrhythmia Services, Johns Hopkins Medical Institutions Baltimore , MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Chin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Groote Schuur Hospital and University of Cape Town , Cape Town,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Coats","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Warwick , Warwickshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Deharo","sequence":"additional","affiliation":[{"name":"Department of Rhythmology, H\u00f4pital Universitaire La Timone , Marseille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Heidb\u00fcchel","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital, University of Antwerp , Edegem,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Isa","sequence":"additional","affiliation":[{"name":"Cl\u00ednica RedSalud Vitacura and Hospital el Carmen de Maip\u00fa , Santiago,","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Kalman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Melbourne Hospital , Melbourne, VIC,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre A","family":"Lane","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital , Liverpool, UK"},{"name":"Aalborg Thrombosis Research Unit, Aalborg University , Aalborg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruan","family":"Louw","sequence":"additional","affiliation":[{"name":"Department Cardiology (Electrophysiology), Mediclinic Midstream Hospital , Centurion,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital , Liverpool, UK"},{"name":"Aalborg Thrombosis Research Unit, Aalborg University , Aalborg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Maury","sequence":"additional","affiliation":[{"name":"Cardiology, University Hospital Rangueil , Toulouse,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"Cardiology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sacher","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Institut Lyric, CHU de Bordeaux , Bordeaux,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital , Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic , Cleveland, OH,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"Service de Cardiologie et Laboratoire d'Electrophysiologie Cardiaque, Centre Hospitalier Universitaire Trousseau et Universit\u00e9 Fran\u00e7ois Rabelais , Tours,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Haugaa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Cardiological Innovation and Institute for Surgical Research, Oslo University Hospital , Oslo,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sarkozy","sequence":"additional","affiliation":[{"name":"Heart Rhythm Management Centre, UZ Brussel-VUB , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[{"name":"St. George's, University of London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Kongsg\u00e5rd","sequence":"additional","affiliation":[{"name":"Department of Cardiology, OUS-Rikshospitalet , Oslo,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Linkoping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"Silesian Center for Heart Disease , Zabrze,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"IRCCS San Raffaele Pisana , Roma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu","family":"Turakhia","sequence":"additional","affiliation":[{"name":"Stanford University, Cardiac Arrhythmia & Electrophysiology Service , Stanford,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isreal W P","family":"Obel","sequence":"additional","affiliation":[{"name":"Parktown West, 2006, Johannesburg , Gauteng,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Abello","sequence":"additional","affiliation":[{"name":"Sanatorio Finochietto, Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Swampillai","sequence":"additional","affiliation":[{"name":"Electrophysiologist & Cardiologist, Waikato Hospital, University of Auckland ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Kalarus","sequence":"additional","affiliation":[{"name":"SMDZ in Zabrze, Medical University of Silesia , Katowice,","place":["Poland"]},{"name":"Department of Cardiology, Silesian Center for Heart Diseases , Zabrze"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulmira","family":"Kudaiberdieva","sequence":"additional","affiliation":[{"name":"Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassil B","family":"Traykov","sequence":"additional","affiliation":[{"name":"Department of Invasive Electrophysiology and Cardiac Pacing, Clinic of Cardiology, Acibadem City Clinic Tokuda Hospital , Sofia,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EHRA Scientific Documents Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Vernooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Kalarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulmira","family":"Kudaiberdieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges H","family":"Mairesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Deneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Hastrup Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassil B","family":"Traykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R","family":"Heinzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"2026080923265637600_euz046-B1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/europace\/eur130","article-title":"Management of patients with palpitations: a position paper from the European Heart Rhythm Association","volume":"13","author":"Raviele","year":"2011","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.hrthm.2016.03.003","article-title":"Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications","volume":"13","author":"Siontis","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612820666140825142639","article-title":"Asymptomatic lone atrial fibrillation\u2014how can we detect the arrhythmia?","volume":"21","author":"Boriani","year":"2015","journal-title":"Curr Pharm Des"},{"key":"2026080923265637600_euz046-B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2016.03.006","article-title":"Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation","volume":"83","author":"Boriani","year":"2016","journal-title":"Vasc Pharmacol"},{"key":"2026080923265637600_euz046-B5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/europace\/eux177","article-title":"Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)","volume":"19","author":"Mairesse","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B7","first-page":"1601","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.hrthm.2004.10.042","article-title":"Relationship between atrial tachyarrhythmias and symptoms","volume":"2","author":"Strickberger","year":"2005","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9343(97)89451-X","article-title":"Evaluation and outcomes of patients with palpitations","volume":"100","author":"Weber","year":"1996","journal-title":"Am J Med"},{"key":"2026080923265637600_euz046-B10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JCN.0000000000000344","article-title":"Symptom clusters in adults with chronic atrial fibrillation","volume":"32","author":"Streur","year":"2017","journal-title":"J Cardiovasc Nurs"},{"key":"2026080923265637600_euz046-B11","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/brain\/awp179","article-title":"Symptoms and signs of syncope: a review of the link between physiology and clinical clues","volume":"132","author":"Wieling","year":"2009","journal-title":"Brain"},{"key":"2026080923265637600_euz046-B12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.1973.sp010147","article-title":"Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings","volume":"229","author":"Malliani","year":"1973","journal-title":"J Physiol"},{"key":"2026080923265637600_euz046-B13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias","volume":"114","author":"Shen","year":"2014","journal-title":"Circ Res"},{"key":"2026080923265637600_euz046-B14","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1113\/JP271870","article-title":"Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics","volume":"594","author":"Shivkumar","year":"2016","journal-title":"J Physiol (Lond)"},{"key":"2026080923265637600_euz046-B15","doi-asserted-by":"crossref","first-page":"346.","DOI":"10.1038\/nrcardio.2014.19","article-title":"Cardiac sympathetic denervation to prevent life-threatening arrhythmias","volume":"11","author":"Schwartz","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2026080923265637600_euz046-B16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00006","article-title":"Palpitations, arrhythmias, and awareness of cardiac activity","volume":"134","author":"Barsky","year":"2001","journal-title":"Ann Intern Med"},{"key":"2026080923265637600_euz046-B17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.pcad.2013.03.001","article-title":"Psychological distress and arrhythmia: risk prediction and potential modifiers","volume":"55","author":"Peacock","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080923265637600_euz046-B18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/europace\/eum090","article-title":"Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion","volume":"9","author":"Varounis","year":"2007","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","article-title":"Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke","volume":"121","author":"Binici","year":"2010","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.amjcard.2013.01.335","article-title":"Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation","volume":"111","author":"Suzuki","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-159-11-201312030-00004","article-title":"Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study","volume":"159","author":"Dewland","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026080923265637600_euz046-B22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jacc.2015.05.018","article-title":"Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation","volume":"66","author":"Larsen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2015.04.069","article-title":"Premature atrial contractions: a wolf in sheep's clothing?","volume":"66","author":"Marcus","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterisation, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/ehw379","article-title":"A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation","volume":"38","author":"Gudbjartsson","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.781","article-title":"A rare variant in MYH6 is associated with high risk of sick sinus syndrome","volume":"43","author":"Holm","year":"2011","journal-title":"Nat Genet"},{"key":"2026080923265637600_euz046-B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/eurheartj\/ehw457","article-title":"Close connections between contraction and rhythm: a new genetic cause of atrial fibrillation\/cardiomyopathy and what it can teach us","volume":"38","author":"Nattel","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B28","doi-asserted-by":"crossref","first-page":"4316.","DOI":"10.1038\/s41467-018-06618-y","article-title":"Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation","volume":"9","author":"Ahlberg","year":"2018","journal-title":"Nat Commun"},{"key":"2026080923265637600_euz046-B29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/STROKEAHA.115.008714","article-title":"Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial","volume":"46","author":"Gladstone","year":"2015","journal-title":"Stroke"},{"key":"2026080923265637600_euz046-B30","first-page":"554","article-title":"The Wolff-Parkinson-White pattern in health aircrew","volume":"52","author":"Davidoff","year":"1981","journal-title":"Aviat Space Environ Med"},{"key":"2026080923265637600_euz046-B31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.25.6.947","article-title":"Electrocardiographic findings in 122,043 individuals","volume":"25","author":"Hiss","year":"1962","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.CIR.87.3.866","article-title":"A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989","volume":"87","author":"Munger","year":"1993","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0954-6820.1969.tb01441.x","article-title":"Wolff-Parkinson-White syndrome. A long-term follow-up of 47 cases","volume":"186","author":"Flensted-Jensen","year":"1969","journal-title":"Acta Med Scand"},{"key":"2026080923265637600_euz046-B34","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.82.5.1718","article-title":"Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern","volume":"82","author":"Leitch","year":"1990","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)","volume":"108","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacc.2008.09.037","article-title":"The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children","volume":"53","author":"Santinelli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM197911153012003","article-title":"Ventricular fibrillation in the Wolff-Parkinson-White syndrome","volume":"301","author":"Klein","year":"1979","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCEP.113.000930","article-title":"Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern","volume":"7","author":"Kubu\u0161","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.eurheartj.a059860","article-title":"Ventricular fibrillation in the Wolff-Parkinson-White syndrome","volume":"12","author":"Montoya","year":"1991","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.111.065722","article-title":"Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study","volume":"125","author":"Pappone","year":"2012","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B41","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa035345","article-title":"A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome","volume":"349","author":"Pappone","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B42","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJMoa040625","article-title":"Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome","volume":"351","author":"Pappone","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B43","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/CIRCULATIONAHA.111.055350","article-title":"Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis","volume":"125","author":"Obeyesekere","year":"2012","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/CIRCULATIONAHA.114.011154","article-title":"Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients","volume":"130","author":"Pappone","year":"2014","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B45","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jacc.2015.09.018","article-title":"Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Al-Khatib","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/europace\/euw301","article-title":"European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)","volume":"19","author":"Katritsis","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","article-title":"Management of atrial high-rate episodes detected by cardiac implanted electronic devices","volume":"14","author":"Freedman","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026080923265637600_euz046-B49","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","article-title":"Device-detected subclinical atrial tachyarrhythmias: definition, implications and management\u2014an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B50","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":". JAMA"},{"key":"2026080923265637600_euz046-B51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)","volume":"74","author":"Furberg","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B52","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists","volume":"99","author":"Levy","year":"1999","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","article-title":"Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Flaker","year":"2005","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation. A systematic review","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost"},{"key":"2026080923265637600_euz046-B55","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.hrthm.2014.03.016","article-title":"Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study","volume":"11","author":"Rienstra","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","article-title":"Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080923265637600_euz046-B58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF pilot general registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med"},{"key":"2026080923265637600_euz046-B59","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2017.08.004","article-title":"Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF registry","volume":"152","author":"Esato","year":"2017","journal-title":"Chest"},{"key":"2026080923265637600_euz046-B60","first-page":"S122.","article-title":"Silent atrial fibrillation in Olmsted County: a community-based study","volume":"27","author":"Tsang","year":"2011","journal-title":"Can J Cardiol"},{"key":"2026080923265637600_euz046-B61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026080923265637600_euz046-B63","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/europace\/euv233","article-title":"Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"17","author":"Lane","year":"2015","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B64","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(00)01077-8","article-title":"Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation","volume":"86","author":"Paquette","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1160\/TH4-04-0383","article-title":"Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study","volume":"112","author":"Martinez","year":"2014","journal-title":"Thromb Haemost"},{"key":"2026080923265637600_euz046-B66","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2026080923265637600_euz046-B67","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman","year":"2016","journal-title":"Lancet (Lond, Engl)"},{"key":"2026080923265637600_euz046-B68","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B69","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1160\/TH15-02-0169","article-title":"Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists","volume":"114","author":"Ruiz-Ortiz","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026080923265637600_euz046-B70","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026080923265637600_euz046-B71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080923265637600_euz046-B72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet (Lond, Engl)"},{"key":"2026080923265637600_euz046-B73","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0038-1641166","article-title":"Comparing non-vitamin K antagonist oral anticoagulants (NOACs) to different Coumadins: the Win-Win scenarios","volume":"118","author":"Potpara","year":"2018","journal-title":"Thromb Haemost"},{"key":"2026080923265637600_euz046-B74","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jamacardio.2016.0393","article-title":"Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation","volume":"1","author":"Freedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080923265637600_euz046-B75","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehx807","article-title":"Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation","volume":"39","author":"Lip","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B76","doi-asserted-by":"crossref","first-page":"f306","DOI":"10.1093\/europace\/euy045","article-title":"A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation","volume":"20","author":"Engdahl","year":"2018","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B77","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B81","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B82","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B84","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2011.10.896","article-title":"Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study","volume":"59","author":"Flaker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B86","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/STROKEAHA.115.009487","article-title":"Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS Trial","volume":"46","author":"Senoo","year":"2015","journal-title":"Stroke"},{"key":"2026080923265637600_euz046-B87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2007.01909.x","article-title":"Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation","volume":"264","author":"Lip","year":"2008","journal-title":"J Intern Med"},{"key":"2026080923265637600_euz046-B88","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ijcard.2012.06.118","article-title":"Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project","volume":"167","author":"Banerjee","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B89","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/europace\/euv390","article-title":"\u2018Real-world\u2019 management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry","volume":"18","author":"Boriani","year":"2016","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B90","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1253\/circj.CJ-14-0507","article-title":"Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation","volume":"78","author":"Inoue","year":"2014","journal-title":"Circ J"},{"key":"2026080923265637600_euz046-B91","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","article-title":"Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry","volume":"46","author":"Takabayashi","year":"2015","journal-title":"Stroke"},{"key":"2026080923265637600_euz046-B92","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B93","first-page":"1543","article-title":"Pathophysiology, diagnosis and treatment of tachycardiomyopathy","volume":"103","author":"Martin","year":"2017","journal-title":"Heart (Br Cardiac Soc)"},{"key":"2026080923265637600_euz046-B94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2011.04.022","article-title":"Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study","volume":"161","author":"Potpara","year":"2012","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B95","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchf.2016.09.016","article-title":"Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation","volume":"5","author":"Pandey","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026080923265637600_euz046-B97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/europace\/euv191","article-title":"European Heart Rhythm Association\/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"18","author":"Lip","year":"2016","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B98","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B99","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jacc.2015.11.064","article-title":"Persistent but not paroxysmal atrial fibrillation is independently associated with lower cognitive function: ARIC study","volume":"67","author":"Chen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/europace\/euy046","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?","volume":"20","author":"Dagres","year":"2018","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B101","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B102","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.amjcard.2013.04.049","article-title":"Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients","volume":"112","author":"Deftereos","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B103","first-page":"1276","article-title":"Effect of intensive blood pressure lowering on incident atrial fibrillation and P-wave indices in the ACCORD blood pressure trial","volume":"29","author":"Chen","year":"2016","journal-title":"journal"},{"key":"2026080923265637600_euz046-B104","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"2026080923265637600_euz046-B105","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: a Long-Term Follow-Up Study (LEGACY)","volume":"65","author":"Pathak","year":"5","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10840-016-0142-5","article-title":"Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation","volume":"46","author":"Bunch","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265637600_euz046-B107","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ahj.2015.07.026","article-title":"Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial","volume":"170","author":"Alonso","year":"15","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B108","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B109","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: the CARDIO-FIT Study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B110","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCULATIONAHA.114.014833","article-title":"Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) project","volume":"131","author":"Qureshi","year":"2015","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B111","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B112","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B113","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2014.07.959","article-title":"Triggering of symptomatic atrial fibrillation by negative emotion","volume":"64","author":"Lampert","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B114","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2012.11.060","article-title":"Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study","volume":"61","author":"Lakkireddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B115","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B116","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2015.10.106","article-title":"Combined impact of healthy lifestyle factors on risk of atrial fibrillation: prospective study in men and women","volume":"203","author":"Larsson","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B117","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B118","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B120","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hrthm.2017.02.001","article-title":"Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: a propensity score-matched analysis","volume":"14","author":"Saliba","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B122","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCEP.113.000597","article-title":"Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis","volume":"7","author":"Chang","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B123","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080923265637600_euz046-B124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/pace.12588","article-title":"Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation","volume":"38","author":"Tran","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCEP.111.962100","article-title":"Natural history and long-term outcomes of ablated atrial fibrillation","volume":"4","author":"Hussein","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B126","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/europace\/eut406","article-title":"Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation","volume":"16","author":"Gaita","year":"2014","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10840-013-9835-1","article-title":"Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes","volume":"38","author":"Winkle","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265637600_euz046-B128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1540-8167.2011.02141.x","article-title":"Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly","volume":"23","author":"Guiot","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B129","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1253\/circj.CJ-11-0065","article-title":"Incidence of late thromboembolic events after catheter ablation of atrial fibrillation","volume":"75","author":"Yagishita","year":"2011","journal-title":"Circ J"},{"key":"2026080923265637600_euz046-B130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCEP.111.963231","article-title":"Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score \u22643: a long-term outcome study","volume":"4","author":"Saad","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B132","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B133","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1540-8167.2009.01481.x","article-title":"Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures","volume":"20","author":"Bunch","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B134","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.2017.1152","article-title":"Postapproval observational studies of non-vitamin K antagonist oral anticoagulants in atrial fibrillation","volume":"317","author":"Potpara","year":"2017","journal-title":"JAMA"},{"key":"2026080923265637600_euz046-B135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B136","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ahj.2018.02.015","article-title":"Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: study rationale and design","volume":"199","author":"Packer","year":"2018","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B137","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/CIRCULATIONAHA.116.024926","article-title":"Should we perform catheter ablation for asymptomatic atrial fibrillation?","volume":"136","author":"Kalman","year":"2017","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B138","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jacc.2010.01.040","article-title":"Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect","volume":"55","author":"Wokhlu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B139","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.12930","article-title":"Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis","volume":"27","author":"Wu","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jce.12467","article-title":"Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival","volume":"25","author":"Mohanty","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B141","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B142","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","article-title":"Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT","volume":"9","author":"Kaufman","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B143","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/eurheartj\/ehx731","article-title":"Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis","volume":"39","author":"Mahajan","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B144","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B145","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"2026080923265637600_euz046-B146","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B147","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B148","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","article-title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","volume":"189","author":"Lopes","year":"2017","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B149","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","article-title":"Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial","volume":"190","author":"Kirchhof","year":"2017","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2016-309632","article-title":"Risk factors for premature ventricular contractions in young and healthy adults","volume":"103","author":"von Rotz","year":"2017","journal-title":"Heart"},{"key":"2026080923265637600_euz046-B151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/heartasia-2016-010854","article-title":"Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies","volume":"9","author":"Lee","year":"2017","journal-title":"Heart Asia"},{"key":"2026080923265637600_euz046-B152","doi-asserted-by":"crossref","first-page":"e0160181.","DOI":"10.1371\/journal.pone.0160181","article-title":"Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"2026080923265637600_euz046-B153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(02)01977-0","article-title":"Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes","volume":"40","author":"Biffi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B154","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.amjcard.2013.05.065","article-title":"Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations","volume":"112","author":"Ataklte","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/jce.12237","article-title":"An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias","volume":"24","author":"Hutchinson","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B156","first-page":"622","article-title":"Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy","volume":"19","author":"Novak","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B157","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ehjci\/jew014","article-title":"Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia","volume":"18","author":"Saberniak","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080923265637600_euz046-B158","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccep.2016.04.001","article-title":"Premature ventricular complexes in apparently normal hearts","volume":"8","author":"Luebbert","year":"2016","journal-title":"Card Electrophysiol Clin"},{"key":"2026080923265637600_euz046-B159","first-page":"e272","article-title":"AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib","year":"2017","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cpcardiol.2015.03.002","article-title":"Premature ventricular complexes and premature ventricular complex induced cardiomyopathy","volume":"40","author":"Latchamsetty","year":"2015","journal-title":"Curr Probl Cardiol"},{"key":"2026080923265637600_euz046-B161","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hrthm.2011.08.015","article-title":"Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy","volume":"9","author":"Yokokawa","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B162","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.hrthm.2011.02.034","article-title":"The role of interpolation in PVC-induced cardiomyopathy","volume":"8","author":"Olgun","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B163","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2013.10.055","article-title":"Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy","volume":"11","author":"Carballeira Pol","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B164","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","author":"Baman","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1540-8167.2010.01986.x","article-title":"Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors","volume":"22","author":"Hasdemir","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B166","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.2011.02021.x","article-title":"Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs","volume":"22","author":"Del Carpio Munoz","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B167","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/europace\/eus371","article-title":"Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease","volume":"15","author":"Ban","year":"2013","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B168","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hrthm.2015.08.025","article-title":"Premature ventricular contraction-induced cardiomyopathy: related clinical and electrophysiologic parameters","volume":"13","author":"Sadron Blaye-Felice","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B169","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ehf2.12180","article-title":"Lower than expected burden of premature ventricular contractions impairs myocardial function","volume":"4","author":"Lie","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026080923265637600_euz046-B170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2017.02.007","article-title":"Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy","volume":"233","author":"Park","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B171","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/pace.12852","article-title":"Longer ambulatory ECG monitoring increases identification of clinically significant ectopy","volume":"39","author":"Loring","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B172","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/hrt.2008.159558","article-title":"Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function","volume":"95","author":"Niwano","year":"2009","journal-title":"Heart"},{"key":"2026080923265637600_euz046-B173","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2015.04.062","article-title":"Ventricular ectopy as a predictor of heart failure and death","volume":"66","author":"Dukes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B174","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B175","first-page":"836","article-title":"Holter monitor findings in asymptomatic male military aviators without structural heart disease","volume":"72","author":"Folarin","year":"2001","journal-title":"Aviat Space Environ Med"},{"key":"2026080923265637600_euz046-B176","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2013.05.026","article-title":"Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging)","volume":"62","author":"Marine","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B177","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-0736(96)80110-5","article-title":"Prognostic value of Holter monitoring in asymptomatic elderly subjects with sinus rhythm","volume":"29","author":"Gheno","year":"1996","journal-title":"J Electrocardiol"},{"key":"2026080923265637600_euz046-B178","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/europace\/eul108","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"8","author":"Zipes","year":"2006","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B179","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.joa.2016.07.002","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"32","author":"Antzelevitch","year":"2016","journal-title":"J Arrhythm"},{"key":"2026080923265637600_euz046-B180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.hrthm.2004.04.021","article-title":"Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome","volume":"1","author":"Shimizu","year":"2004","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B181","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCEP.113.001224","article-title":"Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy","volume":"7","author":"Denis","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B182","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.hrthm.2008.08.032","article-title":"Ventricular arrhythmias originating from a papillary muscle in patients without prior infarction: a comparison with fascicular arrhythmias","volume":"5","author":"Good","year":"2008","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B183","first-page":"277","article-title":"Repetitive monomorphic ventricular tachycardia originating from the inferior tricuspid annulus","volume":"15","author":"Jastrzebski","year":"2008","journal-title":"Cardiol J"},{"key":"2026080923265637600_euz046-B184","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1540-8167.2005.40787.x","article-title":"Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle","volume":"16","author":"Yamauchi","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.recesp.2015.10.016","article-title":"Nonsustained repetitive upper septal idiopathic fascicular left ventricular tachycardia","volume":"69","author":"Arias","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026080923265637600_euz046-B186","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2459\/JCM.0b013e32835ef0b6","article-title":"Clinical spectrum of fascicular tachycardia","volume":"14","author":"Morgera","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown, MD)"},{"key":"2026080923265637600_euz046-B187","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.hrthm.2005.06.009","article-title":"Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia","volume":"2","author":"Lin","year":"2005","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B188","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0167-5273(86)90120-8","article-title":"Persistent ventricular tachycardia resulting in left ventricular dilatation treated with verapamil","volume":"13","author":"Toivonen","year":"1986","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B189","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJM198501243120401","article-title":"Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy","volume":"312","author":"Kennedy","year":"1985","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ancard.2011.05.004","article-title":"Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome","volume":"61","author":"Kane","year":"2012","journal-title":"Ann Cardiol Angeiol"},{"key":"2026080923265637600_euz046-B191","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8159.1996.tb04796.x","article-title":"Tachycardiomyopathy: mechanisms and clinical implications","volume":"19","author":"Fenelon","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B192","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0140-6736(02)07807-8","article-title":"Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation","volume":"359","author":"Haissaguerre","year":"2002","journal-title":"Lancet (Lond, Engl)"},{"key":"2026080923265637600_euz046-B193","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1540-8167.2005.50040.x","article-title":"The \u201cshort-coupled\u201d variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?","volume":"16","author":"Viskin","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B194","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2005.05.077","article-title":"Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract","volume":"46","author":"Noda","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B195","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%","volume":"35","author":"Maury","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B196","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an International Task Force Consensus Statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B197","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B198","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B199","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B200","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJM200006293422602","article-title":"Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death","volume":"342","author":"Buxton","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B201","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B202","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/europace\/euu194","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"16","author":"Pedersen","year":"2014","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B204","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B205","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2018.07.070","article-title":"The mitral annulus disjunction arrhythmic syndrome","volume":"72","author":"Dejgaard","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B206","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2013.02.060","article-title":"Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest","volume":"62","author":"Sriram","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B207","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","article-title":"Arrhythmic mitral valve prolapse and sudden cardiac death","volume":"132","author":"Basso","year":"2015","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B208","first-page":"2733","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B209","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B210","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ijcard.2014.08.068","article-title":"Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function","volume":"176","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B211","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter-defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B212","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/CIRCEP.113.000113","article-title":"Ventricular arrhythmias after left ventricular assist device","volume":"6","author":"Nakahara","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B213","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCEP.114.002394","article-title":"Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices","volume":"8","author":"Sacher","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B214","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","article-title":"Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy","volume":"60","author":"Laurent","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B216","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/europace\/eut160","article-title":"Cardiac characteristics and long-term outcome in Andersen\u2013Tawil syndrome patients related to KCNJ2 mutation","volume":"15","author":"Delannoy","year":"2013","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B217","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.hrthm.2014.09.009","article-title":"Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities","volume":"12","author":"Verdile","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B218","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2016.11.041","article-title":"Isolated subepicardial right ventricular outflow tract scar in athletes with ventricular tachycardia","volume":"69","author":"Venlet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B219","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/clc.20326","article-title":"Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service","volume":"31","author":"Li","year":"2008","journal-title":"Clin Cardiol"},{"key":"2026080923265637600_euz046-B220","first-page":"617","article-title":"Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children","volume":"19","author":"Bertels","year":"2017","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B221","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S1047951110000867","article-title":"Ventricular tachycardia in infants with structurally normal heart: a benign disorder","volume":"20","author":"Levin","year":"2010","journal-title":"Cardiol Young"},{"key":"2026080923265637600_euz046-B222","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCULATIONAHA.107.726372","article-title":"Implantable cardioverter-defibrillators in tetralogy of Fallot","volume":"117","author":"Khairy","year":"2008","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B223","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ijcard.2012.04.103","article-title":"Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot","volume":"167","author":"Koyak","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B224","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2014.12.049","article-title":"Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease","volume":"65","author":"Wong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","article-title":"Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B226","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/europace\/eum033","article-title":"Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator","volume":"9","author":"Rudzinski","year":"2007","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B227","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-218652","article-title":"Melphalan-induced cardiotoxicity: ventricular arrhythmias","author":"Yanamandra","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2026080923265637600_euz046-B228","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0002-9149(99)00892-9","article-title":"Significance of accelerated idioventricular rhythm in idiopathic dilated cardiomyopathy","volume":"85","author":"Grimm","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B229","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1542\/peds.96.1.122","article-title":"Accelerated idioventricular rhythm: a benign arrhythmia in childhood","volume":"96","author":"MacLellan-Tobert","year":"1995","journal-title":"Pediatrics"},{"key":"2026080923265637600_euz046-B230","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B231","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2013.12.180","article-title":"Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management","volume":"172","author":"Gupta","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080923265637600_euz046-B232","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006587","article-title":"Tachycardia-induced cardiomyopathy","author":"Nakatani","year":"2012","journal-title":"BMJ Case Rep"},{"key":"2026080923265637600_euz046-B233","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1751-7133.2010.00147.x","article-title":"Tachycardia-induced cardiomyopathy: evaluation and therapeutic options","volume":"16","author":"Lishmanov","year":"2010","journal-title":"Congest Heart Fail"},{"key":"2026080923265637600_euz046-B234","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"Nerheim","year":"2004","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10840-012-9727-9","article-title":"Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia","volume":"36","author":"Donghua","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265637600_euz046-B236","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.hrthm.2014.04.033","article-title":"Permanent junctional reciprocating tachycardia in children: a multicenter experience","volume":"11","author":"Kang","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B237","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00392-011-0319-y","article-title":"Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study","volume":"100","author":"Nia","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"2026080923265637600_euz046-B238","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.hrthm.2012.04.036","article-title":"Impact of QRS duration of frequent premature ventricular complexes on the development of cardiomyopathy","volume":"9","author":"Yokokawa","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B239","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCEP.113.000681","article-title":"Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B240","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B241","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(16)31277-6","article-title":"Rhythm control in atrial fibrillation","volume":"388","author":"Piccini","year":"2016","journal-title":"Lancet"},{"key":"2026080923265637600_euz046-B242","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B243","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B244","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacep.2018.04.013","article-title":"Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: a substudy of the CAMERA MRI trial","volume":"4","author":"Prabhu","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B245","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B246","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.003993","article-title":"Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study","volume":"9","author":"Garcia","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265637600_euz046-B247","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jacc.2018.06.017","article-title":"His bundle pacing","volume":"72","author":"Vijayaraman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B248","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ejhf.1117","article-title":"Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations","volume":"20","author":"Gasparini","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026080923265637600_euz046-B249","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2011.10.891","article-title":"Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review","volume":"59","author":"Ganesan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265637600_euz046-B250","doi-asserted-by":"crossref","first-page":"e10.","DOI":"10.1067\/mhj.2002.125516","article-title":"Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study","volume":"144","author":"Krittayaphong","year":"2002","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B251","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B252","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080923265637600_euz046-B253","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.105.546432","article-title":"Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract","volume":"112","author":"Yarlagadda","year":"2005","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B254","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.hrthm.2007.03.003","article-title":"Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention","volume":"4","author":"Bogun","year":"2007","journal-title":"Heart Rhythm"},{"key":"2026080923265637600_euz046-B255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-007-9157-2","article-title":"Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions","volume":"20","author":"Taieb","year":"2007","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265637600_euz046-B256","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1540-8167.2005.40786.x","article-title":"Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats","volume":"16","author":"Sekiguchi","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265637600_euz046-B257","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/pace.12087","article-title":"Time course of recovery of left ventricular systolic dysfunction in patients with premature ventricular contraction-induced cardiomyopathy","volume":"36","author":"Hasdemir","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B258","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjcard.2011.04.035","article-title":"Significance of asymptomatic bradycardia for subsequent pacemaker implantation and mortality in patients &gt;60 years of age","volume":"108","author":"Goldberger","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B259","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/oxfordjournals.eurheartj.a059561","article-title":"Minimal heart rates and longest pauses in healthy adult subjects on two occasions eight years apart","volume":"10","author":"Molgaard","year":"1989","journal-title":"Eur Heart J"},{"key":"2026080923265637600_euz046-B260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0022-0736(90)90138-R","article-title":"Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals","volume":"23","author":"Wajngarten","year":"1990","journal-title":"J Electrocardiol"},{"key":"2026080923265637600_euz046-B261","first-page":"1873","article-title":"Cardiac pauses in competitive athletes: a systematic review examining the basis of current practice recommendations","volume":"18","author":"Senturk","year":"2016","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B262","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ahj.2004.01.024","article-title":"Detection of asymptomatic arrhythmias in unexplained syncope","volume":"148","author":"Krahn","year":"2004","journal-title":"Am Heart J"},{"key":"2026080923265637600_euz046-B263","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.amjcard.2008.07.043","article-title":"Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope","volume":"102","author":"Moya","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B264","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0002-9149(85)90735-0","article-title":"Significance of ventricular pauses of three seconds or more detected on twenty-four-hour Holter recordings","volume":"55","author":"Hilgard","year":"1985","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B265","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1136\/thx.53.2008.S29","article-title":"Heart block in patients with sleep apnoea","volume":"53 Suppl 3","author":"Becker","year":"1998","journal-title":"Thorax"},{"key":"2026080923265637600_euz046-B266","first-page":"334","article-title":"Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block","volume":"99","author":"Coumbe","year":"2013","journal-title":"Heart (Br Cardiac Soc)"},{"key":"2026080923265637600_euz046-B267","first-page":"1070","article-title":"ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"15","author":"Brignole","year":"2013","journal-title":"Europace"},{"key":"2026080923265637600_euz046-B268","article-title":"ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay","author":"Kusumoto Fred","year":"2018","journal-title":"Circulation"},{"key":"2026080923265637600_euz046-B269","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.07-0036","article-title":"Depression, anxiety, and quality of life in patients with atrial fibrillation","volume":"132","author":"Thrall","year":"2007","journal-title":"Chest"},{"key":"2026080923265637600_euz046-B270","doi-asserted-by":"crossref","first-page":"100.","DOI":"10.1186\/1477-7525-9-100","article-title":"General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety\u2014a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death","volume":"9","author":"Hamang","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"2026080923265637600_euz046-B271","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/JCN.0b013e3181b7be36","article-title":"Psychological distress in patients diagnosed with atrial fibrillation. The State of the Science","volume":"25","author":"McCabe","year":"2010","journal-title":"J Cardiovasc Nurs"},{"key":"2026080923265637600_euz046-B272","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2013\/159850","article-title":"A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link","volume":"2013","author":"Patel","year":"2013","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"2026080923265637600_euz046-B273","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00044067-200407000-00013","article-title":"Quality of life issues in patients with implantable cardioverter defibrillators: driving, occupation, and recreation","volume":"15","author":"Shea","year":"2004","journal-title":"AACN Clin Issues"},{"key":"2026080923265637600_euz046-B274","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JMDH.S19315","article-title":"What patients want and need to know about atrial fibrillation","volume":"4","author":"McCabe","year":"2011","journal-title":"J Multidiscip Healthc"},{"key":"2026080923265637600_euz046-B275","doi-asserted-by":"crossref","first-page":"160.","DOI":"10.1186\/s12955-016-0561-0","article-title":"Perceptions and experiences of patients living with implantable cardioverter defibrillators: a systematic review and meta-synthesis","volume":"14","author":"Ooi","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2026080923265637600_euz046-B276","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1381612820666140825125715","article-title":"Best practice for atrial fibrillation patient education","volume":"21","author":"Lane","year":"2015","journal-title":"Curr Pharm Des"},{"key":"2026080923265637600_euz046-B277","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008362","article-title":"Patient-reported outcomes in relation to continuously monitored rhythm before and during 2 years after atrial fibrillation ablation using a disease-specific and a generic instrument","volume":"7","author":"Bjorkenheim","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026080923265637600_euz046-B278","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/pace.12276","article-title":"Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients' requests for treatment","volume":"37","author":"Lang","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265637600_euz046-B279","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpsychores.2011.02.014","article-title":"The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review","volume":"71","author":"Magyar-Russell","year":"2011","journal-title":"J Psychosom Res"},{"key":"2026080923265637600_euz046-B280","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.amjcard.2014.12.035","article-title":"Trajectories of patient-reported health status in patients with an implantable cardioverter defibrillator","volume":"115","author":"Mastenbroek","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080923265637600_euz046-B281","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMC.S10628","article-title":"Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials","volume":"7","author":"Pepine","year":"2013","journal-title":"Clin Med Insights Cardiol"},{"key":"2026080923265637600_euz046-B282","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.hrtlng.2009.04.001","article-title":"Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia","volume":"39","author":"Wood","year":"2010","journal-title":"Heart Lung"},{"key":"2026080923265637600_euz046-B283","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ahj.2018.09.002","article-title":"Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: the Apple Heart Study","volume":"207","author":"Turakhia","year":"2019","journal-title":"Am Heart J"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/21\/6\/844\/42806761\/euz046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/21\/6\/844\/42806761\/euz046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:39:51Z","timestamp":1786333191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/21\/6\/844\/5382236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":283,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz046","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,3,18]]}}}